0001209191-23-022465.txt : 20230404 0001209191-23-022465.hdr.sgml : 20230404 20230404083520 ACCESSION NUMBER: 0001209191-23-022465 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230403 FILED AS OF DATE: 20230404 DATE AS OF CHANGE: 20230404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winton Matthew CENTRAL INDEX KEY: 0001971400 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39397 FILM NUMBER: 23795194 MAIL ADDRESS: STREET 1: C/O INOZYME PHARMA, INC. STREET 2: 321 SUMMER STREET, SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inozyme Pharma, Inc. CENTRAL INDEX KEY: 0001693011 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475129768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-330-4340 MAIL ADDRESS: STREET 1: 321 SUMMER STREET STREET 2: SUITE 400 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Inozyme Pharma, LLC DATE OF NAME CHANGE: 20161222 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-03 0 0001693011 Inozyme Pharma, Inc. INZY 0001971400 Winton Matthew C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400 BOSTON MA 02210 0 1 0 0 COO 0 Stock option (right to buy) 5.39 2023-04-03 4 A 0 250000 0.00 A 2033-04-02 Common Stock 250000 250000 D The option was granted on April 3, 2023 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date. /s/ Matthew Winton 2023-04-04